IP Library Granted Patent US 8,571,654
Granted Patent B2
US 8,571,654 · App. 13/352,244 · Granted Oct 29, 2013

Vagus nerve neurostimulator with multiple patient-selectable modes for treating chronic cardiac dysfunction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,571,654
App. No.
13/352,244
Granted
Oct 29, 2013
Kind
B2
Abstract

A vagus nerve neurostimulator system with multiple patient-selectable modes for treating chronic cardiac dysfunction is provided. An implantable neurostimulator includes a pulse generator coupled to a therapy lead terminated by a pair of helical electrodes positioned over a cervical vagus nerve. The pulse generator is configured to deliver through the helical electrodes continuously-cycling, intermittent and periodic electrical stimulation that is parametrically defined to bi-directionally propagate through nerve fibers in the cervical vagus nerve. The implantable neurostimulator includes a magnetic switch configured to switch the pulse generator between a plurality of operating modes that are each separately selectable in response to a unique and remotely-applied magnetic signal. An external controller includes patient-actuatable controls configured to enable selection of one of the operating modes of the pulse generator. The external controller includes an electromagnetic transmitter configured to output the magnetic signal uniquely associated with the operating mode as selected with the controls.

Claims (9)

1. A multi-modal vagus nerve neurostimulator for treating chronic cardiac dysfunction, comprising:

an implantable neurostimulator comprising a pulse generator configured to deliver electrical therapeutic stimulation tuned to restore autonomic balance through continuously-cycling, intermittent and periodic electrical pulses simultaneously delivered at an intensity that avoids acute physiological side effects and with an unchanging cycle not triggered by physiological markers in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers comprising a cervical vagus nerve of a patient through a pair of helical electrodes via an electrically coupled nerve stimulation therapy lead; and

an external electromagnetic controller configured to transmit a plurality of magnetic signals uniquely associated with operating modes stored in a recordable memory, the neurostimulator switching to the corresponding operating mode in response to the magnetic signals.

2. A neurostimulator according to claim 1 , further comprising:

a patient-operable control comprised in the external electromagnetic controller, actuation of which enables separate selection of each of the operating modes and transmission of the magnetic signal corresponding to the operating mode selection.

3. A neurostimulator according to claim 2 , wherein the operating modes stored in the recordable memory comprise one or more of a high therapeutic dosage, therapy titration, therapy suspension, and sleep modes.

4. A neurostimulator according to claim 2 , further comprising:

a patient feedback device comprised in the external electromagnetic controller, which outputs an indication of acceptance of the selected operating mode by the neurostimulator.

5. A neurostimulator according to claim 1 , wherein the electrical therapeutic stimulation is further defined to bi-directionally propagate through neuronal fibers in the cervical vagus nerve by first activating A-fibers of the cervical vagus nerve, then B-fibers of the cervical vagus nerve, and finally C-fibers of the cervical vagus nerve.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
CHANGE OF NAME Recorded Jun 29, 2020
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 053306/0229 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2012
From: LIBBUS, IMAD; AMURTHUR, BADRI; KENKNIGHT, BRUCE H.
To: CYBERONICS, INC.
Reel/Frame 027652/0833 →